Kuo Y, Yu L, Wang H, Chen M, Wu M, Liu C
World J Gastrointest Oncol. 2022; 14(1):55-74.
PMID: 35116103
PMC: 8790410.
DOI: 10.4251/wjgo.v14.i1.55.
Farkhondeh T, Pourbagher-Shahri A, Azimi-Nezhad M, Forouzanfar F, Brockmueller A, Ashrafizadeh M
Molecules. 2021; 26(11).
PMID: 34070502
PMC: 8198360.
DOI: 10.3390/molecules26113157.
Yuan L, Li J, Yang Y, Chen Y, Bu Y, Ye M
Aging (Albany NY). 2021; 13(8):12007-12015.
PMID: 33888645
PMC: 8109083.
DOI: 10.18632/aging.202905.
Lindblad A, Kaucher S, Jaehn P, Kajuter H, Holleczek B, Lissner L
Int J Environ Res Public Health. 2020; 17(24).
PMID: 33317154
PMC: 7763658.
DOI: 10.3390/ijerph17249215.
Kim T, Cheon C, Ko S
Cell Death Dis. 2020; 11(8):717.
PMID: 32879309
PMC: 7468158.
DOI: 10.1038/s41419-020-02924-w.
Precision medicine in gastric cancer.
Bonelli P, Borrelli A, Tuccillo F, Silvestro L, Palaia R, Buonaguro F
World J Gastrointest Oncol. 2019; 11(10):804-829.
PMID: 31662821
PMC: 6815928.
DOI: 10.4251/wjgo.v11.i10.804.
Disruption of the gene in mice using CRISPR/Cas9 promotes body weight reduction and gastric tumorigenesis.
Kim H, Jeong H, Cho Y, Lee J, Nam K, Lee H
Lab Anim Res. 2019; 34(4):257-263.
PMID: 30671113
PMC: 6333602.
DOI: 10.5625/lar.2018.34.4.257.
Gastric cancer: epidemiology, prevention, classification, and treatment.
Sitarz R, Skierucha M, Mielko J, Offerhaus G, Maciejewski R, Polkowski W
Cancer Manag Res. 2018; 10:239-248.
PMID: 29445300
PMC: 5808709.
DOI: 10.2147/CMAR.S149619.
Association between alcohol consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies.
He Z, Zhao T, Xu H, Wang Z, Xu Y, Song Y
Oncotarget. 2017; 8(48):84459-84472.
PMID: 29137439
PMC: 5663611.
DOI: 10.18632/oncotarget.20880.
Nutritional Care of Gastric Cancer Patients with Clinical Outcomes and Complications: A Review.
Choi W, Kim J
Clin Nutr Res. 2016; 5(2):65-78.
PMID: 27152296
PMC: 4855043.
DOI: 10.7762/cnr.2016.5.2.65.
The functional BRCA1 rs799917 genetic polymorphism is associated with gastric cancer risk in a Chinese Han population.
Wang K, Xu L, Pan L, Xu K, Li G
Tumour Biol. 2014; 36(1):393-7.
PMID: 25266802
DOI: 10.1007/s13277-014-2655-9.
Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.
Xia L, Liu Y, Xu X, Jiang P, Ma G, Bu X
World J Gastroenterol. 2014; 20(32):11429-38.
PMID: 25170232
PMC: 4145786.
DOI: 10.3748/wjg.v20.i32.11429.
Advanced or metastatic gastric cancer in elderly patients: clinicopathological, prognostic factors and treatments.
Lu Z, Lu M, Zhou J, Gong J, Gao J, Li J
Clin Transl Oncol. 2012; 15(5):376-83.
PMID: 23054754
DOI: 10.1007/s12094-012-0938-4.
Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment.
Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Kamiya T, Kataoka H
Int J Surg Oncol. 2012; 2012:862879.
PMID: 22778941
PMC: 3384945.
DOI: 10.1155/2012/862879.
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.
Tsushima T, Hironaka S, Boku N, Machida N, Yamazaki K, Yasui H
Int J Clin Oncol. 2011; 18(1):10-6.
PMID: 22020563
DOI: 10.1007/s10147-011-0335-y.
Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer.
Tsushima T, Hironaka S, Boku N, Machida N, Yamazaki K, Yasui H
Gastric Cancer. 2010; 13(4):245-50.
PMID: 21128060
DOI: 10.1007/s10120-010-0566-z.
MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer.
De Re V, Cannizzaro R, Canzonieri V, Cecchin E, Caggiari L, De Mattia E
Tumour Biol. 2010; 31(1):23-32.
PMID: 20237899
PMC: 2803747.
DOI: 10.1007/s13277-009-0004-1.
New perspectives in the treatment of advanced or metastatic gastric cancer.
Rosati G, Ferrara D, Manzione L
World J Gastroenterol. 2009; 15(22):2689-92.
PMID: 19522017
PMC: 2695882.
DOI: 10.3748/wjg.15.2689.
[Evaluation of endoscopic visualisation for identifying premalignant gastric lesions in a Columbian population using histopathology as a reference].
Diaz Perez J, Garcia Ramirez C, Ferreira Bohorquez E, Rivero Rendon L, Olarte Villamizar J, Orozco Vargas L
Aten Primaria. 2009; 41(2):85-9.
PMID: 19231703
PMC: 7665099.
DOI: 10.1016/j.aprim.2008.05.008.
p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.
Abbaszadegan M, Moaven O, Sima H, Ghafarzadegan K, Arabi A, Forghani M
World J Gastroenterol. 2008; 14(13):2055-60.
PMID: 18395906
PMC: 2701527.
DOI: 10.3748/wjg.14.2055.